Yinjie
Wang
ab,
Zhenqi
Jiang
ab,
Bo
Yuan
a,
Yuchen
Tian
a,
Lingchao
Xiang
a,
Yanying
Li
ab,
Yong
Yang
c,
Juan
Li
*a and
Aiguo
Wu
*a
aCixi Institute of Biomedical Engineering, CAS Key Laboratory of Magnetic Materials and Devices, & Key Laboratory of Additive Manufacturing Materials of Zhejiang Province, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, P.R. China. E-mail: aiguo@nimte.ac.cn; lij@nimte.ac.cn
bUniversity of Chinese Academy of Sciences, Beijing 100049, China
cDepartment of Clinical Laboratory, the Affiliated Hospital of Medical School of Ningbo University, Ningbo University School of Medicine, Ningbo, 315010, China
First published on 22nd March 2024
Correction for ‘A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer’ by Yinjie Wang et al., Biomater. Sci., 2019, 7, 4748–4757, https://doi.org/10.1039/C9BM00337A.
The correct Fig. 3 is provided here, and the ESI file has been updated with the correct figures.
An independent expert has viewed the corrected figures and confirmed that they are consistent with the discussions and conclusions presented.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |